Logos Global Management LP insider trades: Verve Therapeutics (VERV) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Logos Global Management LP reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 21, 2021 | VERV | ↑ Buy | 370,000 | $19.00 | $7.0M | Direct | Jun 22, 2021 (1d) |
| Oct 30, 2020 | NVUS | ↑ Buy | 92,040 | $25.44 | $2.3M | See Notes 1 and 2 | Nov 6, 2020 (7d) |
| Oct 30, 2020 | NVUS | ↓ Sell | 12,969 | $26.64 | $346K | See Notes 1 and 2 | Nov 6, 2020 (7d) |
| Sep 21, 2020 | DYN | ↑ Buy | 700,000 | $19.00 | $13.3M | Indirect | Sep 23, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Logos Global Management LP's insider trades
Logos Global Management LP is a 10% owner of Verve Therapeutics (VERV). Since Sep 21, 2020, it has reported 3 open-market purchases worth $22.7M and 1 sale worth $346K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.